1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Dravet Syndrome Thereapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 BIS-001 1.2.3 Cannabidiol 1.2.4 CUR-1916 1.2.5 SAGE-217 1.2.6 Others 1.3 Market by Application 1.3.1 Global Dravet Syndrome Thereapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Dravet Syndrome Thereapeutics Market Perspective (2016-2027) 2.2 Dravet Syndrome Thereapeutics Growth Trends by Regions 2.2.1 Dravet Syndrome Thereapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Dravet Syndrome Thereapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Dravet Syndrome Thereapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Dravet Syndrome Thereapeutics Industry Dynamic 2.3.1 Dravet Syndrome Thereapeutics Market Trends 2.3.2 Dravet Syndrome Thereapeutics Market Drivers 2.3.3 Dravet Syndrome Thereapeutics Market Challenges 2.3.4 Dravet Syndrome Thereapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Dravet Syndrome Thereapeutics Players by Revenue 3.1.1 Global Top Dravet Syndrome Thereapeutics Players by Revenue (2016-2021) 3.1.2 Global Dravet Syndrome Thereapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Dravet Syndrome Thereapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Dravet Syndrome Thereapeutics Revenue 3.4 Global Dravet Syndrome Thereapeutics Market Concentration Ratio 3.4.1 Global Dravet Syndrome Thereapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Dravet Syndrome Thereapeutics Revenue in 2020 3.5 Dravet Syndrome Thereapeutics Key Players Head office and Area Served 3.6 Key Players Dravet Syndrome Thereapeutics Product Solution and Service 3.7 Date of Enter into Dravet Syndrome Thereapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Dravet Syndrome Thereapeutics Breakdown Data by Type 4.1 Global Dravet Syndrome Thereapeutics Historic Market Size by Type (2016-2021) 4.2 Global Dravet Syndrome Thereapeutics Forecasted Market Size by Type (2022-2027) 5 Dravet Syndrome Thereapeutics Breakdown Data by Application 5.1 Global Dravet Syndrome Thereapeutics Historic Market Size by Application (2016-2021) 5.2 Global Dravet Syndrome Thereapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Dravet Syndrome Thereapeutics Market Size (2016-2027) 6.2 North America Dravet Syndrome Thereapeutics Market Size by Type 6.2.1 North America Dravet Syndrome Thereapeutics Market Size by Type (2016-2021) 6.2.2 North America Dravet Syndrome Thereapeutics Market Size by Type (2022-2027) 6.2.3 North America Dravet Syndrome Thereapeutics Market Size by Type (2016-2027) 6.3 North America Dravet Syndrome Thereapeutics Market Size by Application 6.3.1 North America Dravet Syndrome Thereapeutics Market Size by Application (2016-2021) 6.3.2 North America Dravet Syndrome Thereapeutics Market Size by Application (2022-2027) 6.3.3 North America Dravet Syndrome Thereapeutics Market Size by Application (2016-2027) 6.4 North America Dravet Syndrome Thereapeutics Market Size by Country 6.4.1 North America Dravet Syndrome Thereapeutics Market Size by Country (2016-2021) 6.4.2 North America Dravet Syndrome Thereapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Dravet Syndrome Thereapeutics Market Size (2016-2027) 7.2 Europe Dravet Syndrome Thereapeutics Market Size by Type 7.2.1 Europe Dravet Syndrome Thereapeutics Market Size by Type (2016-2021) 7.2.2 Europe Dravet Syndrome Thereapeutics Market Size by Type (2022-2027) 7.2.3 Europe Dravet Syndrome Thereapeutics Market Size by Type (2016-2027) 7.3 Europe Dravet Syndrome Thereapeutics Market Size by Application 7.3.1 Europe Dravet Syndrome Thereapeutics Market Size by Application (2016-2021) 7.3.2 Europe Dravet Syndrome Thereapeutics Market Size by Application (2022-2027) 7.3.3 Europe Dravet Syndrome Thereapeutics Market Size by Application (2016-2027) 7.4 Europe Dravet Syndrome Thereapeutics Market Size by Country 7.4.1 Europe Dravet Syndrome Thereapeutics Market Size by Country (2016-2021) 7.4.2 Europe Dravet Syndrome Thereapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Dravet Syndrome Thereapeutics Market Size (2016-2027) 8.2 Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Type 8.2.1 Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Application 8.3.1 Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Region 8.4.1 Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Dravet Syndrome Thereapeutics Market Size (2016-2027) 9.2 Latin America Dravet Syndrome Thereapeutics Market Size by Type 9.2.1 Latin America Dravet Syndrome Thereapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Dravet Syndrome Thereapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Dravet Syndrome Thereapeutics Market Size by Type (2016-2027) 9.3 Latin America Dravet Syndrome Thereapeutics Market Size by Application 9.3.1 Latin America Dravet Syndrome Thereapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Dravet Syndrome Thereapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Dravet Syndrome Thereapeutics Market Size by Application (2016-2027) 9.4 Latin America Dravet Syndrome Thereapeutics Market Size by Country 9.4.1 Latin America Dravet Syndrome Thereapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Dravet Syndrome Thereapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Dravet Syndrome Thereapeutics Market Size (2016-2027) 10.2 Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Type 10.2.1 Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Application 10.3.1 Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Country 10.4.1 Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Biscayne Pharmaceuticals, Inc. 11.1.1 Biscayne Pharmaceuticals, Inc. Company Details 11.1.2 Biscayne Pharmaceuticals, Inc. Business Overview 11.1.3 Biscayne Pharmaceuticals, Inc. Dravet Syndrome Thereapeutics Introduction 11.1.4 Biscayne Pharmaceuticals, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) 11.1.5 Biscayne Pharmaceuticals, Inc. Recent Development 11.2 GW Pharmaceuticals Plc 11.2.1 GW Pharmaceuticals Plc Company Details 11.2.2 GW Pharmaceuticals Plc Business Overview 11.2.3 GW Pharmaceuticals Plc Dravet Syndrome Thereapeutics Introduction 11.2.4 GW Pharmaceuticals Plc Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) 11.2.5 GW Pharmaceuticals Plc Recent Development 11.3 INSYS Therapeutics, Inc. 11.3.1 INSYS Therapeutics, Inc. Company Details 11.3.2 INSYS Therapeutics, Inc. Business Overview 11.3.3 INSYS Therapeutics, Inc. Dravet Syndrome Thereapeutics Introduction 11.3.4 INSYS Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) 11.3.5 INSYS Therapeutics, Inc. Recent Development 11.4 OPKO Health, Inc. 11.4.1 OPKO Health, Inc. Company Details 11.4.2 OPKO Health, Inc. Business Overview 11.4.3 OPKO Health, Inc. Dravet Syndrome Thereapeutics Introduction 11.4.4 OPKO Health, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) 11.4.5 OPKO Health, Inc. Recent Development 11.5 PTC Therapeutics, Inc. 11.5.1 PTC Therapeutics, Inc. Company Details 11.5.2 PTC Therapeutics, Inc. Business Overview 11.5.3 PTC Therapeutics, Inc. Dravet Syndrome Thereapeutics Introduction 11.5.4 PTC Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) 11.5.5 PTC Therapeutics, Inc. Recent Development 11.6 Sage Therapeutics, Inc. 11.6.1 Sage Therapeutics, Inc. Company Details 11.6.2 Sage Therapeutics, Inc. Business Overview 11.6.3 Sage Therapeutics, Inc. Dravet Syndrome Thereapeutics Introduction 11.6.4 Sage Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) 11.6.5 Sage Therapeutics, Inc. Recent Development 11.7 Xenon Pharmaceuticals Inc. 11.7.1 Xenon Pharmaceuticals Inc. Company Details 11.7.2 Xenon Pharmaceuticals Inc. Business Overview 11.7.3 Xenon Pharmaceuticals Inc. Dravet Syndrome Thereapeutics Introduction 11.7.4 Xenon Pharmaceuticals Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) 11.7.5 Xenon Pharmaceuticals Inc. Recent Development 11.8 Zogenix, Inc. 11.8.1 Zogenix, Inc. Company Details 11.8.2 Zogenix, Inc. Business Overview 11.8.3 Zogenix, Inc. Dravet Syndrome Thereapeutics Introduction 11.8.4 Zogenix, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) 11.8.5 Zogenix, Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Dravet Syndrome Thereapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of BIS-001 Table 3. Key Players of Cannabidiol Table 4. Key Players of CUR-1916 Table 5. Key Players of SAGE-217 Table 6. Key Players of Others Table 7. Global Dravet Syndrome Thereapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Dravet Syndrome Thereapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Dravet Syndrome Thereapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Dravet Syndrome Thereapeutics Market Share by Regions (2016-2021) Table 11. Global Dravet Syndrome Thereapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Dravet Syndrome Thereapeutics Market Share by Regions (2022-2027) Table 13. Dravet Syndrome Thereapeutics Market Trends Table 14. Dravet Syndrome Thereapeutics Market Drivers Table 15. Dravet Syndrome Thereapeutics Market Challenges Table 16. Dravet Syndrome Thereapeutics Market Restraints Table 17. Global Dravet Syndrome Thereapeutics Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Dravet Syndrome Thereapeutics Market Share by Players (2016-2021) Table 19. Global Top Dravet Syndrome Thereapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dravet Syndrome Thereapeutics as of 2020) Table 20. Ranking of Global Top Dravet Syndrome Thereapeutics Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Dravet Syndrome Thereapeutics Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Dravet Syndrome Thereapeutics Product Solution and Service Table 24. Date of Enter into Dravet Syndrome Thereapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Dravet Syndrome Thereapeutics Market Size by Type (2016-2021) (US$ Million) Table 27. Global Dravet Syndrome Thereapeutics Revenue Market Share by Type (2016-2021) Table 28. Global Dravet Syndrome Thereapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Dravet Syndrome Thereapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Dravet Syndrome Thereapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Dravet Syndrome Thereapeutics Revenue Market Share by Application (2016-2021) Table 32. Global Dravet Syndrome Thereapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Dravet Syndrome Thereapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Dravet Syndrome Thereapeutics Market Size by Type (2016-2021) (US$ Million) Table 35. North America Dravet Syndrome Thereapeutics Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Dravet Syndrome Thereapeutics Market Size by Application (2016-2021) (US$ Million) Table 37. North America Dravet Syndrome Thereapeutics Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Dravet Syndrome Thereapeutics Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Dravet Syndrome Thereapeutics Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Dravet Syndrome Thereapeutics Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Dravet Syndrome Thereapeutics Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Dravet Syndrome Thereapeutics Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Dravet Syndrome Thereapeutics Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Dravet Syndrome Thereapeutics Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Dravet Syndrome Thereapeutics Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Dravet Syndrome Thereapeutics Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Dravet Syndrome Thereapeutics Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Dravet Syndrome Thereapeutics Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Dravet Syndrome Thereapeutics Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Dravet Syndrome Thereapeutics Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Dravet Syndrome Thereapeutics Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Dravet Syndrome Thereapeutics Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Dravet Syndrome Thereapeutics Market Size by Country (2022-2027) & (US$ Million) Table 64. Biscayne Pharmaceuticals, Inc. Company Details Table 65. Biscayne Pharmaceuticals, Inc. Business Overview Table 66. Biscayne Pharmaceuticals, Inc. Dravet Syndrome Thereapeutics Product Table 67. Biscayne Pharmaceuticals, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) & (US$ Million) Table 68. Biscayne Pharmaceuticals, Inc. Recent Development Table 69. GW Pharmaceuticals Plc Company Details Table 70. GW Pharmaceuticals Plc Business Overview Table 71. GW Pharmaceuticals Plc Dravet Syndrome Thereapeutics Product Table 72. GW Pharmaceuticals Plc Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) & (US$ Million) Table 73. GW Pharmaceuticals Plc Recent Development Table 74. INSYS Therapeutics, Inc. Company Details Table 75. INSYS Therapeutics, Inc. Business Overview Table 76. INSYS Therapeutics, Inc. Dravet Syndrome Thereapeutics Product Table 77. INSYS Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) & (US$ Million) Table 78. INSYS Therapeutics, Inc. Recent Development Table 79. OPKO Health, Inc. Company Details Table 80. OPKO Health, Inc. Business Overview Table 81. OPKO Health, Inc. Dravet Syndrome Thereapeutics Product Table 82. OPKO Health, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) & (US$ Million) Table 83. OPKO Health, Inc. Recent Development Table 84. PTC Therapeutics, Inc. Company Details Table 85. PTC Therapeutics, Inc. Business Overview Table 86. PTC Therapeutics, Inc. Dravet Syndrome Thereapeutics Product Table 87. PTC Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) & (US$ Million) Table 88. PTC Therapeutics, Inc. Recent Development Table 89. Sage Therapeutics, Inc. Company Details Table 90. Sage Therapeutics, Inc. Business Overview Table 91. Sage Therapeutics, Inc. Dravet Syndrome Thereapeutics Product Table 92. Sage Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) & (US$ Million) Table 93. Sage Therapeutics, Inc. Recent Development Table 94. Xenon Pharmaceuticals Inc. Company Details Table 95. Xenon Pharmaceuticals Inc. Business Overview Table 96. Xenon Pharmaceuticals Inc. Dravet Syndrome Thereapeutics Product Table 97. Xenon Pharmaceuticals Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) & (US$ Million) Table 98. Xenon Pharmaceuticals Inc. Recent Development Table 99. Zogenix, Inc. Company Details Table 100. Zogenix, Inc. Business Overview Table 101. Zogenix, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2016-2021) & (US$ Million) Table 102. Zogenix, Inc. Recent Development Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Global Dravet Syndrome Thereapeutics Market Share by Type: 2020 VS 2027 Figure 2. BIS-001 Features Figure 3. Cannabidiol Features Figure 4. CUR-1916 Features Figure 5. SAGE-217 Features Figure 6. Others Features Figure 7. Global Dravet Syndrome Thereapeutics Market Share by Application: 2020 VS 2027 Figure 8. Clinic Case Studies Figure 9. Hospital Case Studies Figure 10. Others Case Studies Figure 11. Dravet Syndrome Thereapeutics Report Years Considered Figure 12. Global Dravet Syndrome Thereapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Dravet Syndrome Thereapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Dravet Syndrome Thereapeutics Market Share by Regions: 2020 VS 2027 Figure 15. Global Dravet Syndrome Thereapeutics Market Share by Regions (2022-2027) Figure 16. Global Dravet Syndrome Thereapeutics Market Share by Players in 2020 Figure 17. Global Top Dravet Syndrome Thereapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dravet Syndrome Thereapeutics as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Dravet Syndrome Thereapeutics Revenue in 2020 Figure 19. Global Dravet Syndrome Thereapeutics Revenue Market Share by Type (2016-2021) Figure 20. Global Dravet Syndrome Thereapeutics Revenue Market Share by Type (2022-2027) Figure 21. North America Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Dravet Syndrome Thereapeutics Market Share by Type (2016-2027) Figure 23. North America Dravet Syndrome Thereapeutics Market Share by Application (2016-2027) Figure 24. North America Dravet Syndrome Thereapeutics Market Share by Country (2016-2027) Figure 25. United States Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Dravet Syndrome Thereapeutics Market Share by Type (2016-2027) Figure 29. Europe Dravet Syndrome Thereapeutics Market Share by Application (2016-2027) Figure 30. Europe Dravet Syndrome Thereapeutics Market Share by Country (2016-2027) Figure 31. Germany Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Dravet Syndrome Thereapeutics Market Share by Type (2016-2027) Figure 39. Asia-Pacific Dravet Syndrome Thereapeutics Market Share by Application (2016-2027) Figure 40. Asia-Pacific Dravet Syndrome Thereapeutics Market Share by Region (2016-2027) Figure 41. China Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Dravet Syndrome Thereapeutics Market Share by Type (2016-2027) Figure 49. Latin America Dravet Syndrome Thereapeutics Market Share by Application (2016-2027) Figure 50. Latin America Dravet Syndrome Thereapeutics Market Share by Country (2016-2027) Figure 51. Mexico Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Dravet Syndrome Thereapeutics Market Share by Type (2016-2027) Figure 55. Middle East & Africa Dravet Syndrome Thereapeutics Market Share by Application (2016-2027) Figure 56. Middle East & Africa Dravet Syndrome Thereapeutics Market Share by Country (2016-2027) Figure 57. Turkey Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Dravet Syndrome Thereapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Biscayne Pharmaceuticals, Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2016-2021) Figure 61. GW Pharmaceuticals Plc Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2016-2021) Figure 62. INSYS Therapeutics, Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2016-2021) Figure 63. OPKO Health, Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2016-2021) Figure 64. PTC Therapeutics, Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2016-2021) Figure 65. Sage Therapeutics, Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2016-2021) Figure 66. Xenon Pharmaceuticals Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2016-2021) Figure 67. Zogenix, Inc. Revenue Growth Rate in Dravet Syndrome Thereapeutics Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Biscayne Pharmaceuticals, Inc. GW Pharmaceuticals Plc INSYS Therapeutics, Inc. OPKO Health, Inc. PTC Therapeutics, Inc. Sage Therapeutics, Inc. Xenon Pharmaceuticals Inc. Zogenix, Inc.